Sbir PH II "translation of novel biliary tract-specific contrast agent to mediate successful image-guided hepatobiliary interventions"
Active Definitive Contract Awarded Last action
- Contract number
- 140D0426C0062
- Awardee
-
Optosurgical, LLC UEI N5FFBMLQHAJ9
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $2,095,748
Award facts
- Opportunity
-
- A Solicitation of the Advanced Research Projects Agency for Health (ARPA-H) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · 75N91023R00041 · Posted May 17, 2023
- Contract value 100% obligated
- $2,095,748.00 Current and potential, with all options
- Completion date 21% complete
- Current and potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21046, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,095,748 |
About this award
The National Institutes of Health awarded a $2,095,748 definitive contract to Optosurgical, LLC for translation of a novel biliary tract-specific contrast agent to mediate image-guided hepatobiliary interventions on April 8, 2026, under a total small business set-aside.
The contract is an SBIR Phase II award on a firm fixed-price basis with an ultimate completion date of January 9, 2029. Place of performance is Columbia, MD. Optosurgical, a for-profit small business based in Columbia, Maryland, specializes in advanced surgical imaging systems and image-guided interventional technologies. The company operates exclusively as a prime contractor with no subcontract activity and is concentrated entirely within NIH funding, with prior Phase II SBIR awards totaling $3.5 million each for autonomous robotic cholecystectomy system development and intraoperative contrast agents for surgical imaging.
Quick answers
Who was awarded contract 140D0426C0062?
140D0426C0062 was awarded to Optosurgical, LLC by Interior Business Center (Office of Policy Management and Budget) on April 8, 2026.
How much is contract 140D0426C0062 worth?
The government has obligated $2,095,748 on 140D0426C0062.
Which agency awarded contract 140D0426C0062?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0426C0062, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D0426C0062 competed?
The extent of competition for 140D0426C0062 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award